ARTICLE | Clinical News
PEG-hemoglobin oxygen carrier: Began Phase I trial of safety and tolerance
May 8, 1995 7:00 AM UTC
Enzon Inc. (ENZN), Piscataway, N.J. Product: PEG-hemoglobin oxygen carrier Indication: Blood substitute Status: Began Phase I trial of safety and tolerance ...